Affiliation:
1. CCP FSBI «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation
Abstract
The article is devoted to the description of the global experience of personalized prescription of statins. The prerequisites for including the genetic factor, the carriage of the c.521C allele of the gene SLCO1B1, into the statin prescribing algorithm are stated. Also set out the reasons that complicate the introduction of therapeutic drug monitoring of statins into clinical practice are described.